Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Anyone know what our "Cash Position" is at "real time"?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Comment by SouthernTierTomon Mar 29, 2022 10:13am
92 Views
Post# 34555156

RE:Anyone know what our "Cash Position" is at "real time"?

RE:Anyone know what our "Cash Position" is at "real time"?I've been looking for a current CASH position as at march 29 2022

I can't find one, likely not available until May 15 or so..I think??

Any thoughts from those that post here as part of a daily routine?  Shirley an important detail, no??

Bear in mind, it is my opinion only that CV19 has reduced burn due to "limited trial activity" in many of the leading junior bios.

Is this the case for TLT?

Will they indeed need to "top up the kitty" as the program to solved the bladder cancer therapy progresses?

NOBODY ever "coasted into Bethesda on fumes" in ordrer to receive their "stamp of approval"...at least not that I am aware of ...

An "acute story" this "Most read bullboared" subject line..over and over again ...but what about CASH?  Where is the CASH ( aka where is the beef ) ..I like to look from other angles..perhaps less "a-cute"

DO your own due diligence, these internet forums are well...sometimes GRO$$" ; - )
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities